fda approval status bpc 157 2026 BPC-157: The peptide with big claims and scant evidence BPC-157 Before the FDA: Briefing
Description
Do not restart at a higher dose after an illness-related pause
From my first session I started seeing a difference
Left untreated, the deficiency could put you in a wheelchair for life
Morphologically, the finger-like muscle cell endings become shallow and cylindrical or completely atrophied (Figure 12, dashed border)
However, these are theoretical concerns based on mechanism - not established dangers from human studies
